The Losartan Intervention for Endpoint Reduction (LIFE) Trial—Have Angiotensin‐Receptor Blockers Come of Age?-Reference-Cited by-同舟云学术

The Losartan Intervention for Endpoint Reduction (LIFE) Trial—Have Angiotensin‐Receptor Blockers Come of Age?

Published:2002-07 Issue:4 Volume:4 Page:301-305
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:The Journal of Clinical Hypertension

Author:

Sica Domenic A.¹,Weber Michael¹

Affiliation:

1. Domenic A. Sica, MD;¹ Michael Weber, MD² Section of Clinical Pharmacology and Hypertension, Division of Nephrology, Medical College of Virginia of Virginia Commonwealth University, Richmond, VA;¹ and the Office of Scientific Affairs, SUNY Downstate College of Medicine, Brooklyn, NY²

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1524-6175.2002.01099.x

Reference29 articles.

1. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

2. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

3. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study

4. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

5. Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive NephrosclerosisA Randomized Controlled Trial

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship between endothelial-dependent flow-mediated dilation and diastolic function in type 2 diabetes;Acta Diabetologica;2024-06-07

2. ARB and the Slowing of Progression of Diabetic Nephropathy 2001;Top Articles in Primary Care;2023

3. Antihypertensive Drugs;Brenner and Rector's The Kidney;2012

4. Gout, Hyperuricemia, and the Risk of Cardiovascular Disease: Cause and Effect?;Current Rheumatology Reports;2010-03-09

5. A Review of Critical Differences among Loop, Thiazide, and Thiazide-Like Diuretics;Hospital Pharmacy;2009-02